Literature DB >> 20811389

Association between neuropeptide Y receptor 2 polymorphism and the smoking behavior of elderly Japanese.

Naomi Sato1, Shinji Kageyama, Renyin Chen, Masaya Suzuki, Hiroki Mori, Fumihiko Tanioka, Hidetaka Yamada, Takaharu Kamo, Hong Tao, Kazuya Shinmura, Akiko Nozawa, Haruhiko Sugimura.   

Abstract

Molecular heterogeneity of neuropeptide Y (NPY) and its three receptors (1, 2 and 5) has recently been discovered. NPY2R polymorphisms have been shown to be related to cocaine and alcohol dependence in European Americans. To test our hypothesis that these polymorphisms influence the smoking behavior of Japanese population, we investigated the prevalence of the rs4425326 and rs6857715 polymorphisms, which have been suggested to be related to alcohol dependence in European Americans, in 2517 Japanese elderly subjects for whom information on smoking behaviors was available. The prevalence of current smokers was greater among Japanese men having the rs4425326 C allele than ex-smokers. Among the ever-smokers, the Fagerström Test for Nicotine Dependence scores were higher in men having the rs4425326 homozygous T allelotype, and the numbers of cigarettes smoked per day were also significantly higher in the male smokers having the TT genotype. No correlations between the Tobacco Dependence Screener scores and any genotypes were detected. These results suggest that rs4425326 polymorphism may be related to smoking behavior in the Japanese elderly population. This study for the first time suggests NPY2R genotype as a possible genetic factor in nicotine dependence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20811389     DOI: 10.1038/jhg.2010.108

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  6 in total

Review 1.  A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.

Authors:  R L Bell; S Hauser; Z A Rodd; T Liang; Y Sari; J McClintick; S Rahman; E A Engleman
Journal:  Int Rev Neurobiol       Date:  2016-03-21       Impact factor: 3.230

Review 2.  Development of novel pharmacotherapeutics for tobacco dependence: progress and future directions.

Authors:  Dympna Harmey; Patrick R Griffin; Paul J Kenny
Journal:  Nicotine Tob Res       Date:  2012-09-27       Impact factor: 4.244

3.  Association between AKT1 Gene Polymorphism rs2498794 and Smoking-Related Traits with reference to Cancer Susceptibility.

Authors:  Daisuke Nishizawa; Shinya Kasai; Junko Hasegawa; Naomi Sato; Fumihiko Tanioka; Haruhiko Sugimura; Kazutaka Ikeda; Yoh Dobashi
Journal:  Biomed Res Int       Date:  2015-06-07       Impact factor: 3.411

Review 4.  Neuropeptide Y in Alcohol Addiction and Affective Disorders.

Authors:  Annika Thorsell; Aleksander A Mathé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

5.  Insertionally polymorphic sites of human endogenous retrovirus-K (HML-2) with long target site duplications.

Authors:  Tomoaki Kahyo; Hidetaka Yamada; Hong Tao; Nobuya Kurabe; Haruhiko Sugimura
Journal:  BMC Genomics       Date:  2017-06-27       Impact factor: 3.969

6.  Associations between the orexin (hypocretin) receptor 2 gene polymorphism Val308Ile and nicotine dependence in genome-wide and subsequent association studies.

Authors:  Daisuke Nishizawa; Shinya Kasai; Junko Hasegawa; Naomi Sato; Hidetaka Yamada; Fumihiko Tanioka; Makoto Nagashima; Ryoji Katoh; Yasuo Satoh; Megumi Tagami; Hiroshi Ujike; Norio Ozaki; Toshiya Inada; Nakao Iwata; Ichiro Sora; Masaomi Iyo; Mitsuhiko Yamada; Naoki Kondo; Moo-Jun Won; Nobuya Naruse; Kumi Uehara-Aoyama; Masanari Itokawa; Kazutaka Ohi; Ryota Hashimoto; Kumpei Tanisawa; Tomio Arai; Seijiro Mori; Motoji Sawabe; Makiko Naka-Mieno; Yoshiji Yamada; Miki Yamada; Noriko Sato; Masaaki Muramatsu; Masashi Tanaka; Yoko Irukayama-Tomobe; Yuki C Saito; Takeshi Sakurai; Masakazu Hayashida; Haruhiko Sugimura; Kazutaka Ikeda
Journal:  Mol Brain       Date:  2015-08-20       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.